Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Integrin Alpha V Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 MK-0429
  • 1.3.3 C-16Y
  • 1.3.4 264-RAD
  • 1.3.5 AC-301
  • 1.3.6 Others
• 1.4 Market Segment by Application
  • 1.4.1 Global Integrin Alpha V Market Share by Application (2019-2025)
  • 1.4.2 Metabolic Disorders
  • 1.4.3 Ophthalmology
  • 1.4.4 Respiratory
  • 1.4.5 Infectious Disease
  • 1.4.6 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Integrin Alpha V Market Size
  • 2.1.1 Global Integrin Alpha V Revenue 2014-2025
  • 2.1.2 Global Integrin Alpha V Sales 2014-2025
• 2.2 Integrin Alpha V Growth Rate by Regions
  • 2.2.1 Global Integrin Alpha V Sales by Regions 2014-2019
  • 2.2.2 Global Integrin Alpha V Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Integrin Alpha V Sales by Manufacturers
  • 3.1.1 Integrin Alpha V Sales by Manufacturers 2014-2019
  • 3.1.2 Integrin Alpha V Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Integrin Alpha V Revenue by Manufacturers (2014-2019)
  • 3.2.2 Integrin Alpha V Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Integrin Alpha V Market Concentration Ratio (CR5 and HHI)
• 3.3 Integrin Alpha V Price by Manufacturers
• 3.4 Key Manufacturers Integrin Alpha V Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Integrin Alpha V Market
• 3.6 Key Manufacturers Integrin Alpha V Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 MK-0429 Sales and Revenue (2014-2019)
  • 4.1.2 C-16Y Sales and Revenue (2014-2019)
  • 4.1.3 264-RAD Sales and Revenue (2014-2019)
  • 4.1.4 AC-301 Sales and Revenue (2014-2019)
  • 4.1.5 Others Sales and Revenue (2014-2019)
• 4.2 Global Integrin Alpha V Sales Market Share by Type
• 4.3 Global Integrin Alpha V Revenue Market Share by Type
• 4.4 Integrin Alpha V Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Integrin Alpha V Sales by Application

6 United States

• 6.1 United States Integrin Alpha V Breakdown Data by Company
• 6.2 United States Integrin Alpha V Breakdown Data by Type
• 6.3 United States Integrin Alpha V Breakdown Data by Application

7 European Union

• 7.1 European Union Integrin Alpha V Breakdown Data by Company
• 7.2 European Union Integrin Alpha V Breakdown Data by Type
• 7.3 European Union Integrin Alpha V Breakdown Data by Application

8 China

• 8.1 China Integrin Alpha V Breakdown Data by Company
• 8.2 China Integrin Alpha V Breakdown Data by Type
• 8.3 China Integrin Alpha V Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Integrin Alpha V Breakdown Data by Company
• 9.2 Rest of World Integrin Alpha V Breakdown Data by Type
• 9.3 Rest of World Integrin Alpha V Breakdown Data by Application
• 9.4 Rest of World Integrin Alpha V Breakdown Data by Countries
  • 9.4.1 Rest of World Integrin Alpha V Sales by Countries
  • 9.4.2 Rest of World Integrin Alpha V Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Biogen Inc
  • 10.1.1 Biogen Inc Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Integrin Alpha V
  • 10.1.4 Integrin Alpha V Product Introduction
  • 10.1.5 Biogen Inc Recent Development
• 10.2 BioMAS Ltd
  • 10.2.1 BioMAS Ltd Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Integrin Alpha V
  • 10.2.4 Integrin Alpha V Product Introduction
  • 10.2.5 BioMAS Ltd Recent Development
• 10.3 Factor Therapeutics Ltd
  • 10.3.1 Factor Therapeutics Ltd Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Integrin Alpha V
  • 10.3.4 Integrin Alpha V Product Introduction
  • 10.3.5 Factor Therapeutics Ltd Recent Development
• 10.4 MedImmune LLC
  • 10.4.1 MedImmune LLC Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Integrin Alpha V
  • 10.4.4 Integrin Alpha V Product Introduction
  • 10.4.5 MedImmune LLC Recent Development
• 10.5 Merck & Co Inc
  • 10.5.1 Merck & Co Inc Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Integrin Alpha V
  • 10.5.4 Integrin Alpha V Product Introduction
  • 10.5.5 Merck & Co Inc Recent Development
• 10.6 Merck KGaA
  • 10.6.1 Merck KGaA Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Integrin Alpha V
  • 10.6.4 Integrin Alpha V Product Introduction
  • 10.6.5 Merck KGaA Recent Development
• 10.7 Morphic Therapeutic Inc
  • 10.7.1 Morphic Therapeutic Inc Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Integrin Alpha V
  • 10.7.4 Integrin Alpha V Product Introduction
  • 10.7.5 Morphic Therapeutic Inc Recent Development
• 10.8 SciFluor Life Sciences LLC
  • 10.8.1 SciFluor Life Sciences LLC Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Integrin Alpha V
  • 10.8.4 Integrin Alpha V Product Introduction
  • 10.8.5 SciFluor Life Sciences LLC Recent Development
• 10.9 Vascular Pharmaceuticals Inc
  • 10.9.1 Vascular Pharmaceuticals Inc Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Integrin Alpha V
  • 10.9.4 Integrin Alpha V Product Introduction
  • 10.9.5 Vascular Pharmaceuticals Inc Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Integrin Alpha V Sales Channels
  • 11.2.2 Integrin Alpha V Distributors
• 11.3 Integrin Alpha V Customers

12 Market Forecast

• 12.1 Global Integrin Alpha V Sales and Revenue Forecast 2019-2025
• 12.2 Global Integrin Alpha V Sales Forecast by Type
• 12.3 Global Integrin Alpha V Sales Forecast by Application
• 12.4 Integrin Alpha V Forecast by Regions
  • 12.4.1 Global Integrin Alpha V Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Integrin Alpha V Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Integrin Alpha V is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Integrin Alpha V.

This report studies the global market size of Integrin Alpha V, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Integrin Alpha V sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Biogen Inc
BioMAS Ltd
Factor Therapeutics Ltd
MedImmune LLC
Merck & Co Inc
Merck KGaA
Morphic Therapeutic Inc
SciFluor Life Sciences LLC
Vascular Pharmaceuticals Inc

Market Segment by Product Type
MK-0429
C-16Y
264-RAD
AC-301
Others

Market Segment by Application
Metabolic Disorders
Ophthalmology
Respiratory
Infectious Disease
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Integrin Alpha V status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Integrin Alpha V manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Integrin Alpha V are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025